Showing results (81-90 of 331) with videos related to
Sort By:
Pageof 34
European Journal of Cancer (Oxford, England : 1990)|May 8, 2016
Systems immune monitoring in cancer therapyAllison R Greenplate, Douglas B Johnson, P Brent Ferrell, et al.The American Surgeon|May 4, 2023
Margin-Negative en Bloc Resection of a Large Retroperitoneal Melanoma Including Reconstruction of the Infra-renal Inferior Vena CavaHanna L Slutsky, Douglas B Johnson, Patrick Stone, et al.Nature Cardiovascular Research|May 7, 2025
Preclinical mouse models of immune checkpoint inhibitor-associated myocarditisReilly G Fankhauser, Douglas B Johnson, Javid J Moslehi, et al.Journal of Leukocyte Biology|June 20, 2020
Breakthrough concepts in immune-oncology: Cancer vaccines at the bedsideSohini Roy, Tarsheen K Sethi, David Taylor, et al.Med (New York, N.Y.)|March 11, 2023
On the cusp: Considering the impact of artificial intelligence language models in healthcareRachel S Goodman, J Randall Patrinely, Travis Osterman, et al.Expert Review of Clinical Pharmacology|February 1, 2021
Treatment of infections in cancer patients: an update from the neutropenia, infection and myelosuppression study group of the Multinational Association for Supportive Care in Cancer (MASCC)Bernardo L Rapoport, Tim Cooksley, Douglas B Johnson, et al.Expert Review of Precision Medicine and Drug Development|September 6, 2021
Novel insights into the pathogenesis and treatment of NRAS mutant melanomaJeffrey Zhao, Carlos Galvez, Kathryn Eby Beckermann, et al.Chest|May 27, 2023
Update on Biomarkers for the Stratification of Indeterminate Pulmonary NodulesRafael Paez, Michael N Kammer, Nicole T Tanner, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2019
Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathwayRomi Gupta, Suresh Bugide, Biao Wang, et al.Journal of the American Medical Informatics Association : JAMIA|March 31, 2016
Pragmatic precision oncology: the secondary uses of clinical tumor molecular profilingMatthew J Rioth, Ramya Thota, David B Staggs, et al.Pageof 34